P. Datta et al.
CZ-Me (2a). Found (%): C, 61.45; H, 3.96; N, 22.07. Calcd for
C13H10N4O2 (%): C, 61.42; H, 3.94; N, 22.05. FT-IR (KBr disc, νmax, cmꢀ1):
1724 (COO), 1563 (C¼N), 1431 (N¼N). 1H NMR (DMSO-d6; Me4Si,
δ, ppm): 6.50 (m, 8 H), 6.53 (m, 9 H), 7.21 (s, 5 H), 7.33 (s, 4 H),
7.84 (m, 11 H), 8.17 (s, 7 H), 8.20 (d, 12 H, J = 8.2 Hz), 4.09 (s, 1 N-Me).
MS(FAB+), m/z 255 (M + H)+. 13C NMR (DMSO-d6, δ, ppm): 150.6 (C-2);
128.3 (C-4); 130.4 (C-5); 131.6 (C-6); 128.0 (C-7); 136.5 (C- 8); 140.8
(C-9); 160.8 (C-10); 127.3 (C-11); 129.6 (C-12); 148.5 (C-13); 120.4
(C-14); 34.6 (N–Me).
(DMSO-d6, δ, ppm): 157.2 (C-2); 130.5 (C-4); 134.6 (C-5); 139.0 (C-6);
134.5 (C-7); 140.7 (C-8); 144.6 (C-9); 160.7 (C-10); 130.5 (C-11);
130.5 (C-12); 154.7 (C-13); 122.7 (C-14); 28.5 (4-Me), 202.4 (CO).
Microanalytical data are as follows. Anal. Calcd for 3c,
C55H42N4O3P2Os (%): C, 62.21; H, 3.96; N, 5.28. Found (%): C, 62.18;
H, 3.97; N, 5.32. MS (FAB+, 192Os): m/z (% of fragmentation) 1062
(M+H)+ (28%),799[(M+H)+ ꢀPPh3](22%),771[(M+H)+ ꢀ(PPh3 +C
O)] (14%). 1H NMR (DMSO-d6; Me4Si, δ, ppm): 7.45 (o,o’-H of 4-C6H5,
2 H, d, J = 8.5 Hz), 7.22 (m,m’-H of 4-C6H5, 2 H, m), 7.38 (p-H of
4-C6H5, 1 H, m), 7.98 (bs, 5-H), 8.13 (s, 7-H), 6.36 (d, 8-H,
J = 8.7 Hz), 6.41 (d, 9-H, J = 7.0 Hz), 7.56 (m, 11-H), 8.09 (d, 12-H,
J = 7.0 Hz), ꢀ11.61 (Os-H, J = 22.5 for 31P–1 H coupling). 13C NMR
(DMSO-d6, δ, ppm): 159.3 (C-2); 134.4 (C-4); 137.3 (C-5); 142.0 (C-6);
137.0 (C-7); 145.6 (C-8); 148.7 (C-9); 163.5 (C-10); 134.7 (C-11);
137.4 (C-12); 157.5 (C-13); 125.8 (C-14); 127.6 (o,o’-C-Ph); 124.0
(m,m’-C-Ph); 122.5 (p-C-Ph), 205.2 (CO).
CZ-4Me-Me (2b). Found (%): C, 62.71; H, 4.51; N, 20.94. Calcd for
C14H12N4O2 (%): C, 62.69; H, 4.48; N, 20.90. FT-IR (KBr disc, νmax, cmꢀ1):
1
1722 (COO), 1560 (C¼N), 1443 (N¼N). H NMR (DMSO-d6; Me4Si,
δ, ppm): 2.35 (d, 4-Me, J = 9.6 Hz), 6.47 (m, 8 H), 6.51 (m, 9 H),
7.43 (q, 5 H), 7.82 (m, 11 H), 8.06 (s, 7 H), 8.13 (d, 12 H, J = 8.0),
3.95 (s, 1 N-Me). MS(FAB+), m/z 269 (M + H)+. 13C NMR (DMSO-d6,
δ, ppm): 152.6 (C-2); 128.3 (C-4); 127.3 (C-5); 132.5 (C-6); 128.3
(C-7); 139.6 (C-8); 140.3 (C-9); 158.6 (C-10); 128.3 (C-11); 130.3
(C-12); 152.4 (C-13); 120.0 (C-14); 24.0 (C-4-Me); 38.6 (N–Me).
CZ-4Ph-Me (2c). Found (%): C, 69.05; H, 4.28; N, 16.95. Calcd for
C19H14N4O2 (%): C, 69.1; H, 4.2; N, 17.0. FT-IR (KBr disc, νmax, cmꢀ1):
Preparation of [Osh(CO)(PPh3)2(CZ-4Ph-Me)]ClO4 (4c)
In a suspension of [OsHCl(CO)(PPh3)3] (100 mg, 0.096 mmol) in dry
THF (25cm3), 4P-Me (32 mg, 0.097 mmol) in the same solvent was
added and stirred for 8 h under nitrogen atmosphere. After stirring,
a brown-red solution was obtained. The volume of the solution was
reduced under pressure and chromatographed with silica gel
prepared in petroleum ether. A brown-red solution was eluted with
MeOH (with two drops of HClO4 per 100 ml) solution and dried in
vacuum and recrystallised from CH2Cl2–hexane solution.
1
1722 (COO), 1565 (C¼N), 1442 (N¼N). H NMR (DMSO-d6; Me4Si,
δ, ppm): 4.16 (s, 1 N-Me), 7.35–7.61 (m, 4-Ph), 6.45 (d, 8 H,
J = 7.0 Hz), 6.51 (d, 9 H, J = 6.9 Hz), 7.74 (s, 5 H), 7.90 (d, 11 H,
J = 8.4 Hz), 8.18 (s, 7 H), 8.64 (d, 12 H, J = 7.80 Hz). MS(FAB+), m/z
331 (M + H)+. 13C NMR (DMSO-d6, δ, ppm): 151.0 (C-2); 127.8 (C-4);
129.7 (C-5); 123.0 (C-6); 128.9 (C-7); 133.5 (C-8); 138.3 (C-9); 152.5
(C-10); 120.1 (C-11); 122.5 (C-12); 140.6 (C-13); 115.8 (C-14); 126.5
(o,o’-C–Ph); 122.3 (m,m’-C–Ph); 120.6 (p-C–Ph); 37.8 (N–Me).
The other compounds, i.e. [Osh(CO)(PPh3)2(CZ-Me)]ClO4 (4a) and
[Osh(CO)(PPh3)2(CZ-4Me-Me)]ClO4 (4b), were prepared using an
identical procedure.
Preparation of [Osh(CO)(PPh3)2(CZ-4-Ph)] (3c)
Microanalytical data are as follows. Anal. Calcd for 4a,
C50H41N4O7ClP2Os (%): C, 54.57; H, 3.73; N, 5.09. Found (%): C,
54.54; H, 3.78; N, 5.07. Spectral data for 4a. MS (FAB+, 192Os): m/z
(% of fragmentation) 1001 (M + H)+ (19%), 738 [(M + H)+ ꢀ PPh3]
In a 100 ml double-neck round-bottom flask, a mixture of
[OsHCl(CO)(PPh3)3] (100 mg, 0.096 mmol) and CZ-4Ph-H
(30 mg, 0.095 mmol) in nitrogen atmosphere was added in
dry THF (40 cm3) and heated to 90°C for 12 h. The colour of
the solution changed to dark red. The solvent was removed
under vacuum and the residue was separated by silica gel column
chromatography. A blood red-coloured solution was eluted with
acetonitrile–benzene (1:5, v/v) solution. Single crystals of [Osh(CO)
(PPh3)2(CZ-4Ph)] suitable for X-ray diffraction studies were obtained
from a CH2Cl2–hexane solution at room temperature.
1
(16%), 710 [(M + H)+ ꢀ (PPh3 + CO)] (21%). H NMR (DMSO-d6;
Me4Si, δ, ppm): 7.54 (bs, 4-H), 7.51 (bs, 5-H), 7.87 (s,7-H), 6.47
(d, 8-H, J = 8.0 Hz), 6.50 (d, 9-H, J = 7.5 Hz), 7.38 (m, 11-H), 7.70
(d, 12-H, J = 7.2 Hz), 4.02 (s, N(1)-Me), ꢀ12.53 (Os-H, J = 24.0
for 31P–1 H coupling). 13C NMR (DMSO-d6, δ, ppm): 157.5 (C-2);
134.5 (C-4); 135.8 (C-5); 138.9 (C-6); 133.5 (C-7); 143.5 (C-8);
146.5 (C-9); 161.2 (C-10); 131.2 (C-11); 133.6 (C-12); 153.6 (C-13);
123.5 (C-14); 35.3 (N(1)–Me), 206.5 (CO).
The other compounds, i.e. [Osh(CO)(PPh3)2(CZ)] (3a) and
[Osh(CO)(PPh3)2(CZ-4Me)] (3b), were prepared using an
identical procedure.
Microanalytical data are as follows. Anal. Calcd for 4b,
C51H43N4O7ClP2Os (%): C, 54.96; H, 3.86; N, 5.03. Found: C, 55.01;
H, 3.82; N, 5.01. Spectral data for 4b. MS (FAB+, 192Os): m/z (% of
fragmentation) 1015 (M + H)+ (24%), 752 [(M + H)+ ꢀ PPh3] (18%),
Microanalytical data are as follows. Anal. Calcd for 3a,
C49H38N4O3P2Os (%): C, 59.70; H, 3.86; N, 5.69. Found (%): C, 59.68;
H, 3.82; N, 5.76. Spectral data for 3a. MS (FAB+, 192Os): m/z (% of
fragmentation) 986 (M + H)+ (20%), 723 [(M + H)+ ꢀ PPh3] (18%),
1
724 [(M + H)+ ꢀ (PPh3 + CO)] (21%). H NMR (DMSO-d6; Me4Si,
δ, ppm): 2.28 (s, 4-Me), 7.55 (bs, 5-H), 7.78 (s, 7-H), 6.37 (d, 8-H,
J = 8.4 Hz), 6.50 (m, 9-H), 7.48 (m, 11-H), 7.58 (d, 12-H, J = 7.8 Hz),
1
695 [(M + H)+ ꢀ (PPh3 + CO)] (22%). H NMR (DMSO-d6; Me4Si,
δ, ppm): 7.62 (bs, 4-H), 7.55 (bs, 5-H), 7.66 (s, 7-H), 6.39 (d, 8-H,
J = 8.5 Hz), 6.42 (d, 9-H, J = 8.8 Hz), 7.48 (m, 11-H), 7.68 (d, 12-H,
J = 7.3 Hz), ꢀ11.03 (Os-H, J = 22.5 for 31P–1 H coupling). 13C NMR
(DMSO-d6, δ, ppm): 158.9 (C-2); 133.7 (C-4); 136.4 (C-5); 140.9 (C-6);
135.6 (C-7); 144.3 (C-8); 147.4 (C-9); 162.7 (C-10); 132.4 (C-11);
134.6 (C-12); 155.4 (C-13); 124.4 (C-14); 204.2 (CO).
4.15 (s, N(1)–Me), ꢀ13.68 (Os-H, J = 20.0 for 31P–1 H coupling). 13
C
NMR (DMSO-d6, δ, ppm): 155.7 (C-2); 130.0 (C-4); 133.4 (C-5); 138.4
(C-6); 132.4 (C-7); 139.8 (C-8); 143.6 (C-9); 160.1 (C-10); 128.9 (C-11);
132.0 (C-12); 153.4 (C-13); 121.7 (C-14); 36.0 (N(1)–Me), 28.0 (4-Me),
204.9 (CO).
Microanalytical data are as follows. Anal. Calcd for 4c,
C56H45N4O7ClP2Os (%): C, 57.17; H, 3.83; N, 4.76. Found (%): C,
57.22; H, 3.84; N, 4.81. Spectral data for 4c. MS (FAB, 192Os): m/z
(% of fragmentation) 1077 (M + H)+ (22%), 813 [(M + H)+ ꢀ PPh3]
Microanalytical data are as follows. Anal. Calcd for 3b,
C50H40N4O3P2Os (%): C, 60.06; H, 4.00; N, 5.61. Found (%): C, 60.10;
H, 3.97; N, 5.63. Spectral data for 3b. MS (FAB+, 192Os): m/z (% of
fragmentation) 1000 (M + H)+ (25%), 737 [(M + H)+ ꢀ PPh3] (19%),
1
(16%), 785 [(M + H)+ ꢀ (PPh3 + CO)] (23%). H NMR (DMSO-d6;
1
709 [(M + H)+ ꢀ (PPh3 + CO)] (16%). H NMR (DMSO-d6; Me4Si,
Me4Si, δ, ppm): 7.49 (o,o’-H of 4-C6H5, 2 H, d, J = 8.5 Hz), 7.20
(m,m’-H of 4-C6H5, 2 H, m), 7.35 (p-H of 4-C6H5, 1 H, m), 7.94 (bs,
5-H), 8.22 (s, 7-H), 6.44 (d, 8-H, J = 8.2 Hz), 6.50 (d, 9-H, J = 7.2 Hz),
7.57 (m, 11-H), 7.68 (d, 12-H, J = 7.4 Hz), ꢀ13.69 (Os-H, J = 20.0 for
δ, ppm): 2.01 (s, 4-Me), 7.64 (bs, 5-H), 7.76 (s,7-H), 6.37 (d, 8-H,
J = 8.5 Hz), 6.40 (d, 9-H, J = 8.8 Hz), 7.48 (m, 11-H), 7.67 (d, 12-H,
J = 7.5 Hz), ꢀ11.50 (Os-H, J = 23.0 for 31P–1 H coupling). 13C NMR
wileyonlinelibrary.com/journal/aoc
Copyright © 2016 John Wiley & Sons, Ltd.
Appl. Organometal. Chem. 2016, 30, 323–334